Review of Alzheimer’s Disease: Treatments and New Pharmacological Strategies
نویسندگان
چکیده
منابع مشابه
A Review of Pharmacological Treatments of NASH
Background: Non-alcoholic fatty liver disease (NAFLD) encompasses the entire spectrum of fatty liver disease in individuals without significant alcohol consumption and affects up to a third of the population in many developed countries. Approximately 10-30% of patients with NAFLD will progress to non-alcoholic steatohepatitis (NASH), which is associated with hepatocellular injury and inflammati...
متن کاملNew trends in pharmacological treatments of endometriosis
Endometriosis is a chronic disease characterized by dysmenorrhoea, dyspareunia, pelvic pain, and infertility. Endometriosis is often treated surgically upon diagnosis but with a high rate of recurrence, suggesting that a combination of surgical and medical management might provide better outcomes. The goal of medical treatment is to interrupt the growth and activity of endometriotic lesions, du...
متن کاملA brief review of the latest pharmacological treatments of COVID-19
New Coronavirus which is called 2019-Novel-Coronavirus (2019-nCoV) or Severe acute respiratory Syndrome-Coronavirus 2 (SARS-Cov-2) causes deadly pneumonia that first appeared in December 2019 in Wuhan city in China. This virus spreads over the world quickly and made several problems to the community and health care system. Several drugs have been tried to manage COVID-19; however, our knowledge...
متن کاملInvestigational Pharmacological Treatments for Parkinson’s Disease
Effective therapy for Parkinson’s disease (PD) has existed for 40 years. Currently, levodopa, the precursor to dopamine, remains the most consistently effective medication. Most other pharmacologic treatments, such as dopamine agonists, augment and replace the endogenous dopamine loss that causes PD symptoms. Other treatments such as anticholinergic medications and amantadine often help symptom...
متن کاملAlzheimers Disease: Review of Emerging Treatment Role for Intravenous Immunoglobulins
Alzheimer's disease (AD) is the most common neurodegenerative disorder. Currently available therapies are symptomatic but do not alter underlying disease progression. Immunotherapeutic approaches such as anti Aβ peptide active vaccination trials have had limited success to date. Intravenous immunoblobulin (IVIg) is widely used in immune-mediated neurological disorders such myasthenia gravis and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmaceutical Science and Technology
سال: 2019
ISSN: 2640-4532
DOI: 10.11648/j.pst.20190301.12